BMS-F
BMS-F is a chemical from the aminoalkylindole family invented by Bristol-Myers Squibb around 1999, that acts as a potent and selective agonist for the cannabinoid receptor CB 2 , with a K i of 8 nM at CB 2 and 500x selectivity over the…
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
BMS-F is a chemical from the aminoalkylindole family invented by Bristol-Myers Squibb around 1999, that acts as a potent and selective agonist for the cannabinoid receptor CB 2 , with a K i of 8 nM at CB 2 and 500x selectivity over the related CB 1 receptor. It has antiinflammatory effects and inhibits release of TNF-α.
BMS-F is a chemical from the aminoalkylindole family invented by Bristol-Myers Squibb around 1999, that acts as a potent and selective agonist for the cannabinoid receptor CB 2 , with a K i of 8 nM at CB 2 and 500x selectivity over the related CB 1 receptor. It has antiinflammatory effects and inhibits release of TNF-α.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1337832248 under CC BY-SA 4.0; modifications have been made.